MIRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MIRA Pharmaceuticals Inc is not a strong buy for a beginner, long-term investor at this time. The stock lacks positive catalysts, has weak financial performance, and no significant trading signals or trends. While the technical indicators show some neutral to slightly positive signals, the overall lack of growth and absence of influential factors make this stock a 'hold' rather than a buy.
The MACD is slightly positive and expanding, indicating mild bullish momentum. RSI is neutral at 52.136, showing no overbought or oversold conditions. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its pivot level of 1.051, with support at 1.002 and resistance at 1.101. Overall, the technical indicators suggest a neutral to slightly bearish trend.
NULL identified. No recent news or significant events to drive the stock upward.
Weak financial performance with no revenue growth and significant net losses. No insider or hedge fund activity to indicate confidence in the stock.
In Q4 2025, the company reported no revenue growth (0% YoY), a net loss of -5,983,321 (up 149.34% YoY), and a negative EPS of -0.15 (up 7.14% YoY). Gross margin remains at 0%. Overall, the financials indicate poor performance with no signs of growth.
No analyst rating or price target data available.
